Helping Doctors Share in Price-Discounted Contracts
One of the problems large, national hospital groups have run into in doing contracts for physician-preferred products is that physicians themselves don't share in the savings that result from their willingness to compromise product choice. Now some product companies are looking for ways to let physicians benefit as well, without triggering fraud and abuse regulations.
You may also be interested in...
The US FDA released five device-related close-out letters in March.
Governments around the world should designate all medicines as ‘priority essential products’, the IGBA has urged, as a surge in demand coinciding with a reduction in the number of flights and rising freight costs are making it more difficult for suppliers to meet global requirements amid the coronavirus pandemic.
In a letter to the medtech industry, the FDA’s William Maisel says the US agency will hold remote meetings with device makers and other stakeholders through the end of May. The FDA also extended due dates for marketing applications by 90 days.